NCT05361369 - Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 9, 2022

Primary Completion Date

May 13, 2022

Study Completion Date

March 15, 2023

Conditions

Bioavailability

Interventions

DRUG

EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule

Fixed dose combination of 600 mg fenticonazole nitrate + 1000 mg tinidazole + 100 mg lidocaine

Trial Locations (1)

Erciyes University Hakan Çetinsaya İyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP), Kayseri